share_log

Analyst Ratings For Pacira BioSciences

パシラバイオサイエンシズのアナリスト評価

Benzinga ·  05/08 14:00

6 analysts have shared their evaluations of Pacira BioSciences (NASDAQ:PCRX) during the recent three months, expressing a mix of bullish and bearish perspectives.

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings42000
Last 30D10000
1M Ago10000
2M Ago00000
3M Ago22000

Insights from analysts' 12-month price targets are revealed, presenting an average target of $46.67, a high estimate of $57.00, and a low estimate of $43.00. This current average has decreased by 4.76% from the previous average price target of $49.00.

price target chart

Understanding Analyst Ratings: A Comprehensive Breakdown

The perception of Pacira BioSciences by financial experts is analyzed through recent analyst actions...

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする